The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Leon Volchyok

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Leon Volchyok is a private equity based in New York across 709 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Leon Volchyok on Proptech.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Leon Volchyok — Private Equity
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Leon Volchyok — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Leon Volchyok — 709
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Leon Volchyok — Proptech

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Leon Volchyok — Private Equity · New York · 709 tracked deals · Leon Volchyok portfolio

Similar investors

• Pal B. Ristvedt
• Strategic Equity Capital NY LLC
• Magnus Grimeland
• Elodie Dupuy
• Victor L. Wu
• Timothy Huang
• Opto Custom GP 2023 LLC
• Antler Special Opportunities GP II LLC
• Steven G. Glenn
• Tom Newby

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Leon Volchyok · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory